Namouni Fouad

CIK 00018158513 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001815851

Recent Transactions

37 trades

Award
Vor Biopharma Inc.$VOR
Stock Option (right to buy)
2026-06-11+56,549→ 56,549 total
Disposition to Issuer
Blueprint Medicines Corp
Common Stock
2025-07-17−83,281→ 31,956 total
Award
Blueprint Medicines Corp
Common Stock
2025-07-17+39,456→ 115,237 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−26,400→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−30,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−30,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−30,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−26,125→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−65,000→ 0 total
Disposition from Tender
Blueprint Medicines Corp
Common Stock
2025-07-17−31,956→ 0 total
Award
Vor Biopharma Inc.$VOR
Stock Option (Right to Buy)
2025-05-22+30,000→ 30,000 total
Sale
Blueprint Medicines Corp
Common Stock
2025-03-05$88.80/sh−6,489→ 75,781 total
Award
Blueprint Medicines Corp
Common Stock
2025-03-01+13,200→ 82,270 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-03-01+26,400→ 26,400 total
Sale
Blueprint Medicines Corp
Common Stock
2024-10-03$89.32/sh−3,633→ 69,070 total
Award
Vor Biopharma Inc.$VOR
Stock Option (Right to Buy)
2024-05-23+30,000→ 30,000 total
Award
Vor Biopharma Inc.$VOR
Stock Option (right to buy)
2024-04-30+60,000→ 60,000 total
Sale
Blueprint Medicines Corp
Common Stock
2024-03-07$90.69/sh−4,377→ 72,703 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2024-03-01+30,000→ 30,000 total
Award
Blueprint Medicines Corp
Common Stock
2024-03-01+15,000→ 77,080 total
Sale
Blueprint Medicines Corp
Common Stock
2023-10-04$48.06/sh−3,769→ 62,080 total
Sale
Blueprint Medicines Corp
Common Stock
2023-03-06$44.36/sh−63→ 65,849 total
Sale
Blueprint Medicines Corp
Common Stock
2023-03-06$45.72/sh−1,885→ 65,912 total
Award
Blueprint Medicines Corp
Common Stock
2023-03-01+15,000→ 67,797 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2023-03-01+30,000→ 30,000 total
Sale
Blueprint Medicines Corp
Common Stock
2022-10-04$67.30/sh−3,477→ 52,797 total
Sale
Blueprint Medicines Corp
Common Stock
2022-03-07$56.19/sh−1,047→ 56,274 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2022-03-01+30,000→ 30,000 total
Award
Blueprint Medicines Corp
Common Stock
2022-03-01+15,000→ 57,321 total
Sale
Blueprint Medicines Corp
Common Stock
2021-10-05$98.18/sh−3,241→ 42,321 total
Award
Aprea Therapeutics, Inc.$APRE
Common Stock
2021-06-30+4,610→ 4,610 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Option (Right to Buy)
2021-06-30+22,750→ 22,750 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2021-03-01+26,125→ 26,125 total
Award
Blueprint Medicines Corp
Common Stock
2021-03-01+13,062→ 45,562 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2020-10-01+65,000→ 65,000 total
Award
Blueprint Medicines Corp
Common Stock
2020-10-01+32,500→ 32,500 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Option (right to Buy)
2020-06-26+7,000→ 7,000 total

Companies

Recent Filings

Address

500 BOYLSTON STREET, SUITE 1350

BOSTON, MA, 02116

View on SEC.gov